Код жизни. Как защитить себя от развития злокачественных новообразований и сохранить тело здоровым до глубокой старости. Джейсон Фанг
id="n_4">
4
J. C. Bailar III and E. M. Smith, “Progress Against Cancer?” New England Journal of Medicine 314, no. 19 (May 8, 1986): 1226–32.
5
Barron H. Lerner, “John Bailar’s Righteous Attack on the ‘War on Cancer,’ ” Slate, January 12, 2017, https://slate.com/technology/2017/01/john-bailar-reminded-us-of-the-value-of-evidence.html.
6
Clifton Leaf, The Truth in Small Doses (New York: Simon & Schuster, 2013), p. 25.
7
J. C. Bailar III and H. L. Gornik, “Cancer Undefeated,” New England Journal of Medicine 336, no. 22 (May 29, 1997): 1569–74.
8
https://www.nytimes.com/2009/04/24/health/policy/24cancer.html.
9
https://www.newyorker.com/tech/annals-of-technology/world-warcancer.
10
https://www.nytimes.com/2009/08/06/opinion/06watson.html.
11
https://slate.com/human-interest/2013/02/where-do-the-millions-of-cancer-research-dollars-go-every-year.html.
12
Siddhartha Mukherjee, The Emperor of all Maladies (New York: Simon & Schuster, 2010), p. 6.
13
https://www.cbc.ca/news/health/anesthesia-death-rates-improve-over-50-years-1.1200837.
14
E. H. Grubbe, “Priority in the Therapeutic Use of X-rays,” Radiology 21 (1933): 156–62.
15
M. A. Cleaves, “Radium: With a Preliminary Note on Radium Rays in the Treatment of Cancer,” Medical Record 64 (1903): 601–6.
16
E. B. Krumbhaar, “Role of the Blood and the Bone Marrow in Certain Forms of Gas Poisoning: I. Peripheral Blood Changes and Their Significance,” JAMA, 72 (1919): 39–41.
17
I. Berenblum et al., “The Modifying Influence of Dichloroethyl Sulphide on the Induction of Tumours in Mice by Tar,” Journal of Pathology and Bacteriology 32 (1929): 424–34.
18
https://scienceblog.cancerresearchuk.org/2014/08/27/mustard-gas-from-the-great-war-to-frontline-chemotherapy/.
19
R. J. Papac, “Origins of Cancer Therapy,” Yale Journal of Biology and Medicine 74 (2001): 391–98.
20
S. Farber et al., “Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-aminopteroyl-glutamic acid (aminopterin),” New England Journal of Medicine 238 (1948): 787–93.
21
M. C. Li, R. Hertz, and D. M. Bergenstal, “Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine Antagonists,” New England Journal of Medicine 259 (1958): 66–74.
22
E. J. Freireich, M. Karon, and E. Frei III, “Quadruple Combination Therapy (VAMP) for Acute Lymphocytic Leukemia of Childhood,” Proceedings of the American Association for Cancer Research 5 (1964): 20.
23
V. T. DeVita, A. A. Serpick, and P. P. Carbone, “Combination Chemotherapy in the Treatment of Advanced Hodgkin’s Disease,” Annals of Internal Medicine 73 (1970): 881–95.
24
Письмо Чарльза Дарвина Джозефу Долтону Гукеру, 1 августа 1857 г., DCPLETT-2130, Darwin Correspondence Project, https://www.darwinproject.ac.uk/letter/?docId=letters/DCP-LETT-2130.xml;query=DCP-LETT-2130;brand=default.
25
D. Hanahan and R. A. Weinberg, “The Hallmarks of Cancer,” Cell 100, no. 1 (January 2000): 57–70.
26
D. Hanahan and R. A. Weinberg, “Hallmarks of Cancer: The Next Generation,” Cell 144, no. 5 (March 4, 2011): 646–74, doi: 10.1016/j.cell.2011.02.013.
27
A. G. Renehan et al., “What Is Apoptosis, and Why Is It important?” BMJ 322 (2001): 1536–38.
28
J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: A Basic Biological Phenomenon with Wide-Ranging Implications in Tissue Kinetics,” British Journal of Cancer 26, no. 4 (August 1972): 239–57.
29
J. W. Shay et al., “Hayflick, His Limit, and Cellular Ageing,” Nature Reviews Molecular Cell Biology 1, no. 1 (October 2000): 72–76, doi: 10.1038/35036093.
30
G. Watts, “Leonard Hayflick and the Limits of Ageing,” The Lancet 377, no. 9783 (June 18, 2011): 2075, doi: 10.1016/S0140–6736(11)60908–2.
31
https://www.theguardian.com/world/2010/apr/04/henrietta-lacks-cancer-cells.